Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
University of Michigan (INC)
Search grants from University of Michigan (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A Brief Intervention to Increase Size-Appropriate Child Passenger Restraint Use
Health Benefits and Cost of Human Milk Feedings for Very Low Birthweight Infants
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
Eukaryotic Bioluminescent Integrated Circuit Sensors
Regulation of HLA Genes in Small Cell Lung Cancer
Recently added grants:
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
Noradrenergic biomarkers in PTSD: precision medicine & mechanisms
Brain Function and Connectivity in Methamphetamine Dependence: The Link to Neuroinflammation and the Effects of Ibudilast
Neural Links of Approach Bias Modification in Heavy Drinking Veterans
Spontaneous EEG Activity in Psychosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025025-002
Application #
6828861
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Michigan (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
/ University of Michigan (INC)
NIH 2002
N01 CA
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
/ University of Michigan (INC)
Comments
Be the first to comment on this grant